Treatment of anxiety disorders

Abstract

This invention relates to the treatment of anxiety disorders. The invention furthermore relates to novel pharmaceutical compositions comprising a therapeutically effective amount of the compound exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)- chromen-2-one, or a therapeutically effective amount of the compound exo-7-(8-H-8- aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-oneand a benzodiazepine drug.

Description

technical field The present invention relates to the treatment of anxiety disorders. The present invention also relates to compound exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)-benzopyran-2-one or A therapeutically effective amount of compound exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)-benzopyran-2-one and benzodiazepines novel pharmaceutical compositions. Background technique Anxiety disorders represent a significant public health problem and impose an economic burden on society. A number of medications have been or are being developed to treat anxiety disorders. Among the preferred drugs are benzodiazepine drugs. These medications are effective in reducing anxiety symptoms quickly. However, the body rapidly develops tolerance to the therapeutic effects of these drugs and the doses required to induce a beneficial effect often need to be increased, creating unwanted side effects. Importantly, long-term treatment with these drugs often leads to dependence. As a result,...

AI Technical Summary

Problems solved by technology

However, the body rapidly develops tolerance to the therapeutic effects of these drugs and the doses required to induce beneficial effects often need to be increased, creating unwanted side effects

Importantly, long-term treatment with these drugs often leads to dependence

As a result, benzodiazepines are good for short-term help but generally should not be used for longer term